About UCSF Search UCSF UCSF Medical Center

Peter Bacchetti, PhD


Adjunct Professor, Department of Epidemiology and Biostatistics, UCSF


Phone: (415) 476-9844 (voice)
Box 0560, UCSF
San Francisco, CA 94143-0560

View on UCSF Profiles


University of California, Berkeley, California, BA, 1980, Philosophy and Statistics
Stanford University, Stanford, California, MS, 1982, Statistics
University of California, Berkeley, California, PhD, 1987, Biostatistics

Professional Experience

  • 11/82-7/85
    Statistician, Department of Epidemiology and Biostatistics, UCSF
  • 8/85-12/87
    Senior Statistician, Department of Epidemiology and Biostatistics, UCSF
  • 1/88-6/93
    Adjunct Assistant Professor, Department of Epidemiology and Biostatistics, UCSF
  • 7/93-7/99
    Adjunct Associate Professor, Department of Epidemiology and Biostatistics, UCSF
  • 11/93-present
    Director, Biostatistical Consulting Unit, Department of Epidemiology and Biostatistics, UCSF
  • 07/99-present
    Adjunct Professor, Department of Epidemiology and Biostatistics, UCSF

Honors & Awards

  • 1980
    Phi Beta Kappa
  • 1980
    Statistics Departmental Citation (outstanding graduating senior), University of California, Berkeley
  • 1988
    First place, Biometric Society 1987-88 student paper competition (Western North American Region)
  • 1998
    Mortimer Spiegelman Award for outstanding contributions to health statistics, American Public Health Association
  • 2004
    Fellow of the American Statistical Association

Selected Publications

  1. Hickey MD, Salmen CR, Tessler RA, Omollo D, Bacchetti P, Magerenge R, Mattah B, Salmen MR, Zoughbie D, Fiorella KJ, Geng E, Njoroge B, Jin C, Huang Y, Bukusi EA, Cohen CR, Gandhi M. Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural kenya. J Acquir Immune Defic Syndr. 2014 Jul 1; 66(3):311-5.
    View on PubMed
  2. Bacchetti P, Shelhamer MJ. Commentaries on Viewpoint: Justifying small-n research in scientifically amazing settings: Challenging the notion that only "big-n" studies are worthwhile. J Appl Physiol (1985). 2014 May; 116(9):1253.
    View on PubMed
  3. Looney MR, Roubinian N, Gajic O, Gropper MA, Hubmayr RD, Lowell CA, Bacchetti P, Wilson G, Koenigsberg M, Lee DC, Wu P, Grimes B, Norris PJ, Murphy EL, Gandhi MJ, Winters JL, Mair DC, Schuller RM, Hirschler NV, Rosen RS, Matthay MA, Toy P. Prospective Study on the Clinical Course and Outcomes in Transfusion-Related Acute Lung Injury. Crit Care Med. 2014 Apr 25.
    View on PubMed
  4. Hatano H, Bacchetti P, Hsue PY, Deeks SG. Reply to Karch et al. J Infect Dis. 2014 Jul 1; 210(1):159-60.
    View on PubMed
  5. Liu AY, Yang Q, Huang Y, Bacchetti P, Anderson PL, Jin C, Goggin K, Stojanovski K, Grant R, Buchbinder SP, Greenblatt RM, Gandhi M. Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP). PLoS One. 2014; 9(1):e83736.
    View on PubMed
  6. Baxi SM, Greenblatt RM, Bacchetti P, Scherzer R, Minkoff H, Huang Y, Anastos K, Cohen M, Gange SJ, Young M, Shlipak MG, Gandhi M. Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women. AIDS. 2014 Jan 2; 28(1):59-66.
    View on PubMed
  7. Wheeler AL, Scherzer R, Lee D, Delaney JA, Bacchetti P, Shlipak MG, Sidney S, Grunfeld C, Tien PC. HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection. AIDS. 2014 Jan 2; 28(1):49-58.
    View on PubMed
  8. Spivak AM, Andrade A, Eisele E, Hoh R, Bacchetti P, Bumpus NN, Emad F, Buckheit R, McCance-Katz EF, Lai J, Kennedy M, Chander G, Siliciano RF, Siliciano JD, Deeks SG. A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy. Clin Infect Dis. 2014 Mar; 58(6):883-90.
    View on PubMed
  9. Josefsson L, von Stockenstrom S, Faria NR, Sinclair E, Bacchetti P, Killian M, Epling L, Tan A, Ho T, Lemey P, Shao W, Hunt PW, Somsouk M, Wylie W, Douek DC, Loeb L, Custer J, Hoh R, Poole L, Deeks SG, Hecht F, Palmer S. The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci U S A. 2013 Dec 17; 110(51):E4987-96.
    View on PubMed
  10. Gandhi M, Yang Q, Bacchetti P, Huang Y. Short communication: a low-cost method for analyzing nevirapine levels in hair as a marker of adherence in resource-limited settings. AIDS Res Hum Retroviruses. 2014 Jan; 30(1):25-8.
    View on PubMed
  11. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E. Association of multiple sclerosis susceptibility variants and early attack location in the CNS. PLoS One. 2013; 8(10):e75565.
    View on PubMed
  12. Hatano H, Yukl SA, Ferre AL, Graf EH, Somsouk M, Sinclair E, Abdel-Mohsen M, Liegler T, Harvill K, Hoh R, Palmer S, Bacchetti P, Hunt PW, Martin JN, McCune JM, Tracy RP, Busch MP, O'Doherty U, Shacklett BL, Wong JK, Deeks SG. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog. 2013; 9(10):e1003691.
    View on PubMed
  13. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E. Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. PLoS One. 2013; 8(10):e75416.
    View on PubMed
  14. Hatano H, Strain MC, Scherzer R, Bacchetti P, Wentworth D, Hoh R, Martin JN, McCune JM, Neaton JD, Tracy RP, Hsue PY, Richman DD, Deeks SG. Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. J Infect Dis. 2013 Nov 1; 208(9):1436-42.
    View on PubMed
  15. Patterson S, Moran P, Epel E, Sinclair E, Kemeny ME, Deeks SG, Bacchetti P, Acree M, Epling L, Kirschbaum C, Hecht FM. Cortisol patterns are associated with T cell activation in HIV. PLoS One. 2013; 8(7):e63429.
    View on PubMed
  16. Jain V, Hartogensis W, Bacchetti P, Hunt PW, Hatano H, Sinclair E, Epling L, Lee TH, Busch MP, McCune JM, Pilcher CD, Hecht FM, Deeks SG. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis. 2013 Oct 15; 208(8):1202-11.
    View on PubMed
  17. Bacchetti P. Small sample size is not the real problem. Nat Rev Neurosci. 2013 Aug; 14(8):585.
    View on PubMed
  18. Castillo-Trivino T, Braithwaite D, Bacchetti P, Waubant E. Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One. 2013; 8(7):e66308.
    View on PubMed
  19. Plankey M, Bacchetti P, Jin C, Dass-Brailsford P, Gustafson D, Cohen MH, Karim R, Yin M, Tien PC. The association of self-perception of body fat changes and quality of life in the Women's Interagency HIV Study. AIDS Care. 2013 Dec; 25(12):1544-50.
    View on PubMed
  20. Murphy EL, Kwaan N, Looney MR, Gajic O, Hubmayr RD, Gropper MA, Koenigsberg M, Wilson G, Matthay M, Bacchetti P, Toy P. Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med. 2013 Apr; 126(4):357.e29-38.
    View on PubMed

Go to UCSF Profiles, powered by CTSI